ELIZABETH GILBREATH: Open Payments
NPI 1477572295 · CENTRE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 39 payments from 9 companies in 2025. Trend: 2023 $727 · 2024 $576 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 21 | $198 |
| AstraZeneca Pharmaceuticals LP | 9 | $183 |
| Verona Pharma, Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Novo Nordisk Inc | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $15 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, BREZTRI, JARDIANCE, Ohtuvayre, Ozempic, VRAYLAR, OTEZLA.
Industry payments across AL — which companies pay providers there.
